21st January 2020 Content supplied by: Creative Diagnostics
Creative Diagnostics Launches New ASFV Antigens and Antibodies for Research
As a global leading supplier of raw materials, antibodies, and reagents for the biotechnology industry, Creative Diagnostics launches a large range of p30 antigens and antibodies for ASFV detection.
All of the Creative Diagnostics ASFV antibodies and antigens are manufactured to the highest quality standards have been validated to work in various types of immunoassays. African swine fever (ASF) is a highly contagious haemorrhagic viral disease of domestic and wild boars.
The pathogen of ASF is African swine fever virus (ASFV). It is a large, double-stranded DNA virus, the only member of the Asfarviridae family, genus Asfivirus and the only DNA virus transmitted by arthropods, soft ticks of the Ornithodoros genus. And currently, there is no approved vaccine for ASF. Due to the lack of an effective vaccine against this virus, the early diagnosis has become very critical for ASF control. Among the structural proteins that compose the virion of ASFV, p30 is one of the most immunogenic proteins and is produced during early stage of ASFV infection. These two characteristics make p30 a good target for diagnostic assays to detect ASFV infection.
Creative Diagnostics now offers customers with p30 antigens and antibodies for ASFV detection, including products like Rabbit Rabbit Anti-ASFV p30 polyclonal antibody for ELISA, WB, Recombinant African Swine Fever Virus p30 Protein from Insect Cells [Tag], and Mouse Anti-ASFV p30 monoclonal antibody for ELISA, IF, IHC, IP, WB.
For example, the Recombinant ASFV P30 Protein [His], is expressed in E.coli as a his-tag fusion protein (210 aa,>95%, ~24.4 kda). "For research scientists to accurately get their ASFV detection results and make progress in their projects, they need access to a reliable supplier that are offering credible biological materials and tools. Creative Diagnostics is a better choice for them as we know the challenges the scientific community is facing through our years of experience and industry expertise. Our new antigens and antibodies maintain the consistently high standard that can enable our customers reliable ASFV detection data." says Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.
"Creative Diagnostics is committed to developing life science products and services that deliver significant efficiency to our global customers. With these new detection antigens and antibodies and related custom services, researchers now can be assured of the reliability of their results within several business days. We're very excited and proud to be able to offer this biological resource to the scientific community." said Prof. Mike Knuth, M.D., the chief scientific officer of R&D department of Creative Diagnostics.
If you want to know more information about ASFV antibodies and antigens or other products, please contact Creative Diagnostics at +1-631-619-7922 or use the 'request information' button below.
About Creative DiagnosticsCreative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs.
Date Published: 21st January 2020
Source article link: View
EFSA ask Stakeholders for Input
Training in Aseptic Techniques Helps